:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Lymphoma Cancer News
Lymphoma Cancer Breakthrough News
  Nov 26, 2008
Tumor Surroundings Influence Survival in Diffuse Large-B-Cell Lymphoma
  By Michael Smith, North American Correspondent, MedPage Today

BETHESDA, Md., Nov. 26 -- Survival after treatment for diffuse large-B-cell lymphoma is influenced not only by the cancer, but by the tumor microenvironment, researchers here said.    <READ MORE>

  Mar. 20, 2008
FDA Okays Bendamustine (Treanda) for CLL
  By Todd Neale, Staff Writer, MedPage Today

FRAZER, Pa., March 20 -- The FDA has approved bendamustine (Treanda) to treat chronic lymphocytic leukemia, announced Cephalon, U.S. developer of the drug.    <READ MORE>

  Mar. 13, 2008
Radioimmunotherapy After Chemotherapy Effective for Non-Hodgkin Lymphoma
  By Judith Groch, Senior Writer, MedPage Today

BOLOGNA, Italy, March 13 -- For untreated follicular non-Hodgkin lymphoma, adding the radioactive drug yttrium-90 ibritumomab tiuxetan to standard chemotherapy is safe and effective as frontline therapy, a phase II trial found.   <READ MORE>

  Feb. 1, 2008
High-Dose Methotrexate Prolongs Life in Brain Lymphomas
  By Judith Groch, Senior Writer, MedPage Today

BOSTON, Feb. 1 -- After nearly seven years, five of 12 patients maintained a complete response to treatment with high-dose methotrexate alone for a primary central nervous system lymphoma.  <READ MORE>

  Jan. 15, 2008
Rituximab Plus CHOP Boosts Survival in Older Lymphoma Patients
  By Charles Bankhead, Staff Writer, MedPage Today

HOMBURG, Germany, Jan. 15 -- Older patients with aggressive B-cell lymphomas had significantly better outcomes when rituximab (Rituxan), the anti-CD20 antibody, was added to CHOP chemotherapy, researchers here found.  <READ MORE>

  Dec. 10, 2007
ASH: Radioimmunotherapeutic Consolidation a Plus for Follicular Lymphoma
  By Charles Bankhead, Staff Writer, MedPage Today

ATLANTA, Dec. 10 -- For advanced follicular lymphoma, consolidation of first remission with radioimmunotherapy significantly prolonged progression-free survival, showed early results of a multicenter clinical trial.  <READ MORE>

  Dec. 10, 2007
ASH: Intensified Immunochemotherapy Offers Mantle Cell Lymphoma Cure Potential
  By Charles Bankhead, Staff Writer, MedPage Today

ATLANTA, Dec. 10 -- An intensive immunochemotherapy regimen may be curative for some patients with mantle cell lymphoma, a Nordic research team said here.   <READ MORE>

 

Oct 20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007" held in New York, NY.

 

By Ruben Niesvizky, MD

Emerging therapeutic strategies for multiple myeloma: Proteasome inhibitors and immunomodulators
<CLICK HERE TO VIEW WEBCAST>

 

Oct 20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007" held in New York, NY.

 

By David G. Maloney, MD, PhD

Frontline management of follicular non-Hodgkin lymphoma (NHL): Novel anti-CD20 therapies
<CLICK HERE TO VIEW WEBCAST>

 

Oct 20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007" held in New York, NY.

 

By John P. Leonard, MD

Novel therapeutic options for mantle cell lymphoma
<CLICK HERE TO VIEW WEBCAST>

   

 

:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough News ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

 
Copyright ⓒ ICare.  All rights reserved.